# LandBridge Corp: financial statements, quarterly

LB · NYSE · CIK 1995807 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lb.md) · [Financials](/companies/lb/financials.md) · [Filings](/companies/lb/filings.md) · [Insiders](/companies/lb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lb/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [17.8](/filings/0000950170-24-122700.md) | [17.5 d](/filings/0001193125-26-072404.md) | [19.0](/filings/0000950170-25-066008.md) | [26.0](/filings/0000950170-25-102232.md) | [28.5](/filings/0001193125-25-277992.md) | [36.5 d](/filings/0001193125-26-072404.md) | [44.0](/filings/0001193125-26-209491.md) | [47.5](/filings/0001193125-26-335650.md) | [50.8](/filings/0001193125-25-277992.md) | [56.8 d](/filings/0001193125-26-072404.md) | [51.0](/filings/0001193125-26-209491.md) | [66.8](/filings/0001193125-26-335650.md) |
| Operating income | $m | [19.1](/filings/0000950170-24-122700.md) | [5.4 d](/filings/0001193125-26-072404.md) | [13.5](/filings/0000950170-25-066008.md) | [(51.2)](/filings/0000950170-25-102232.md) | [3.2](/filings/0001193125-25-277992.md) | [18.0 d](/filings/0001193125-26-072404.md) | [25.0](/filings/0001193125-26-209491.md) | [28.5](/filings/0001193125-26-335650.md) | [30.9](/filings/0001193125-25-277992.md) | [34.1 d](/filings/0001193125-26-072404.md) | [29.2](/filings/0001193125-26-209491.md) | [44.2](/filings/0001193125-26-335650.md) |
| Income tax | $m | [0.1](/filings/0000950170-24-122700.md) | [0.1 d](/filings/0001193125-26-072404.md) | [0.1](/filings/0000950170-25-066008.md) | [0.1](/filings/0000950170-25-102232.md) | [(1.1)](/filings/0001193125-25-277992.md) | [2.8 d](/filings/0001193125-26-072404.md) | [1.6](/filings/0001193125-26-209491.md) | [2.1](/filings/0001193125-26-335650.md) | [2.7](/filings/0001193125-25-277992.md) | [2.6 d](/filings/0001193125-26-072404.md) | [1.8](/filings/0001193125-26-209491.md) | [3.9](/filings/0001193125-26-335650.md) |
| Net income | $m | [16.6](/filings/0000950170-24-122700.md) | [2.5 d](/filings/0001193125-26-072404.md) | [10.8](/filings/0000950170-24-093065.md) | [(57.7)](/filings/0000950170-24-093065.md) | [2.7](/filings/0001193125-25-277992.md) | [2.5 d](/filings/0001193125-26-072404.md) | [6.5](/filings/0001193125-26-209491.md) | [7.5](/filings/0001193125-26-335650.md) | [8.1](/filings/0001193125-25-277992.md) | [8.1 d](/filings/0001193125-26-072404.md) | [8.7](/filings/0001193125-26-209491.md) | [12.3](/filings/0001193125-26-335650.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | [(0.04)](/filings/0001193125-25-277992.md) | not reported | [0.20](/filings/0001193125-26-209491.md) | [0.24](/filings/0001193125-26-335650.md) | [0.26](/filings/0001193125-25-277992.md) | not reported | [0.23](/filings/0001193125-26-209491.md) | [0.40](/filings/0001193125-26-335650.md) |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | [0.15](/filings/0001193125-25-277992.md) | not reported | [0.27](/filings/0001193125-26-209491.md) | [0.30](/filings/0001193125-26-335650.md) | [0.31](/filings/0001193125-25-277992.md) | not reported | [0.31](/filings/0001193125-26-209491.md) | [0.43](/filings/0001193125-26-335650.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [37.8](/filings/0000950170-25-034049.md) | not reported | [24.6](/filings/0000950170-24-093065.md) | [14.4](/filings/0000950170-24-122700.md) | [37.0](/filings/0001193125-26-072404.md) | [14.9](/filings/0000950170-25-066008.md) | [20.3](/filings/0000950170-25-102232.md) | [28.3](/filings/0001193125-25-277992.md) | [30.7](/filings/0001193125-26-335650.md) | [29.7](/filings/0001193125-26-209491.md) | [39.8](/filings/0001193125-26-335650.md) |
| Current assets | $m | not reported | [52.3](/filings/0000950170-25-034049.md) | not reported | [41.5](/filings/0000950170-24-093065.md) | [31.6](/filings/0000950170-24-122700.md) | [53.3](/filings/0001193125-26-072404.md) | [43.6](/filings/0000950170-25-066008.md) | [44.1](/filings/0000950170-25-102232.md) | [57.4](/filings/0001193125-25-277992.md) | [59.8](/filings/0001193125-26-335650.md) | [59.3](/filings/0001193125-26-209491.md) | [70.8](/filings/0001193125-26-335650.md) |
| Total assets | $m | not reported | [289](/filings/0000950170-25-034049.md) | not reported | [710](/filings/0000950170-24-093065.md) | [690](/filings/0000950170-24-122700.md) | [1,032](/filings/0001193125-26-072404.md) | [1,037](/filings/0001193125-25-277992.md) | [1,066](/filings/0000950170-25-102232.md) | [1,078](/filings/0001193125-25-277992.md) | [1,366](/filings/0001193125-26-335650.md) | [1,362](/filings/0001193125-26-209491.md) | [1,377](/filings/0001193125-26-335650.md) |
| Current liabilities | $m | not reported | [27.1](/filings/0000950170-25-034049.md) | not reported | [50.4](/filings/0000950170-24-093065.md) | [43.3](/filings/0000950170-24-122700.md) | [14.4](/filings/0001193125-26-072404.md) | [11.8](/filings/0000950170-25-066008.md) | [10.4](/filings/0000950170-25-102232.md) | [13.8](/filings/0001193125-25-277992.md) | [12.3](/filings/0001193125-26-335650.md) | [18.8](/filings/0001193125-26-209491.md) | [9.7](/filings/0001193125-26-335650.md) |
| Total liabilities | $m | not reported | [138](/filings/0000950170-25-034049.md) | not reported | [414](/filings/0000950170-24-093065.md) | [286](/filings/0000950170-24-122700.md) | [395](/filings/0001193125-26-072404.md) | [387](/filings/0000950170-25-066008.md) | [381](/filings/0000950170-25-102232.md) | [380](/filings/0001193125-25-277992.md) | [572](/filings/0001193125-26-335650.md) | [554](/filings/0001193125-26-209491.md) | [545](/filings/0001193125-26-335650.md) |
| Long-term debt | $m | not reported | [108](/filings/0000950170-25-034049.md) | not reported | [361](/filings/0000950170-24-093065.md) | [242](/filings/0000950170-24-122700.md) | [381](/filings/0001193125-26-072404.md) | [375](/filings/0000950170-25-066008.md) | [371](/filings/0000950170-25-102232.md) | [366](/filings/0001193125-25-277992.md) | [560](/filings/0001193125-26-335650.md) | [535](/filings/0001193125-26-209491.md) | [536](/filings/0001193125-26-335650.md) |
| Current portion of debt | $m | not reported | [20.3](/filings/0000950170-25-034049.md) | not reported | [35.1](/filings/0000950170-24-093065.md) | [35.5](/filings/0000950170-24-122700.md) | [0.4](/filings/0001193125-26-072404.md) | [0.3](/filings/0000950170-25-066008.md) | [0.2](/filings/0000950170-25-102232.md) | [0.9](/filings/0001193125-25-277992.md) | [0.7](/filings/0001193125-26-335650.md) | [0.4](/filings/0001193125-26-209491.md) | [0.2](/filings/0001193125-26-335650.md) |
| Shareholders' equity | $m | [141](/filings/0000950170-24-122700.md) | [151](/filings/0000950170-25-034049.md) | [162](/filings/0000950170-24-122700.md) | [296](/filings/0000950170-24-122700.md) | [97.2](/filings/0000950170-24-122700.md) | [212](/filings/0001193125-26-072404.md) | [217](/filings/0001193125-25-277992.md) | [266](/filings/0000950170-25-102232.md) | [272](/filings/0001193125-25-277992.md) | [340](/filings/0001193125-26-335650.md) | [344](/filings/0001193125-26-209491.md) | [356](/filings/0001193125-26-335650.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [16.2 d](/filings/0000950170-24-122700.md) | [12.5 d](/filings/0001193125-26-072404.md) | [17.2](/filings/0000950170-25-066008.md) | [16.0 d](/filings/0000950170-25-102232.md) | [7.5 d](/filings/0001193125-25-277992.md) | [26.9 d](/filings/0001193125-26-072404.md) | [15.9](/filings/0001193125-26-209491.md) | [37.3 d](/filings/0001193125-26-335650.md) | [34.9 d](/filings/0001193125-25-277992.md) | [38.1 d](/filings/0001193125-26-072404.md) | [41.1](/filings/0001193125-26-209491.md) | [41.4 d](/filings/0001193125-26-335650.md) |
| Capital expenditure | $m | [0.2 d](/filings/0000950170-24-122700.md) | [0.1 d](/filings/0001193125-26-072404.md) | [0.1](/filings/0000950170-25-066008.md) | [0.4 d](/filings/0000950170-25-102232.md) | [0.3 d](/filings/0001193125-25-277992.md) | [0.2 d](/filings/0001193125-26-072404.md) | [0.1](/filings/0001193125-26-209491.md) | [1.2 d](/filings/0001193125-26-335650.md) | [1.2 d](/filings/0001193125-25-277992.md) | [1.7 d](/filings/0001193125-26-072404.md) | [0.2](/filings/0001193125-26-209491.md) | [1.1 d](/filings/0001193125-26-335650.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | [171 d](/filings/0001193125-25-277992.md) | [7.4 d](/filings/0001193125-26-072404.md) | [13.6](/filings/0001193125-26-209491.md) | [24.4 d](/filings/0001193125-26-335650.md) | [14.9 d](/filings/0001193125-25-277992.md) | [10.9 d](/filings/0001193125-26-072404.md) | [14.7](/filings/0001193125-26-209491.md) | [18.6 d](/filings/0001193125-26-335650.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [73.2](/filings/0001193125-25-277992.md) | [76.5](/filings/0001193125-26-209491.md) | [76.4](/filings/0001193125-26-335650.md) | [76.5](/filings/0001193125-25-277992.md) | [77.1](/filings/0001193125-26-209491.md) | [77.0](/filings/0001193125-26-335650.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.